Zonadhesin: A Potential Drug Target and Biomarker (G7455)

Target Name: ZAN

NCBI ID: G7455

Zonadhesin: A Potential Drug Target and Biomarker

Zonadhesin (ISO Form 3), also known as CSAN-3, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the zinc finger transcription factor (ZNF) family and is involved in the regulation of gene expression and cellular processes. ZAN has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The zinc finger transcription factor (ZNF) family is a family of non-coding RNA-protein hybrid molecules that play a central role in the regulation of gene expression. ZNF family members are characterized by the presence of a zinc finger domain and a nucleotide- binding oligomerization domain (NBD). The ZAN protein is a member of the ZNF family and is characterized by its ability to bind to specific DNA sequences and regulate gene expression.

ZAN is expressed in various tissues of the body, including the brain, heart, and kidneys, and has been shown to play a role in the regulation of cellular processes, including cell growth, differentiation, and inflammation. ZAN has also been shown to be involved in the regulation of inflammation and has been used as a potential therapeutic target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key challenges in the study of ZAN is its complex structure and the difficulty of studying its function in living organisms. Despite its involvement in several cellular processes, little is known about its specific functions and how it contributes to the regulation of cellular processes . This lack of understanding has made it difficult to develop effective therapies for ZAN-related diseases.

In addition to its potential therapeutic applications, ZAN is also of interest as a drug target. The ability of ZAN to regulate gene expression and cellular processes makes it a potential target for small molecules and other therapeutic agents. Several studies have shown that inhibitors of ZAN can have a therapeutic effect on various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. However, the precise mechanism of action of these inhibitors and their potential therapeutic applications is not well understood.

In conclusion, ZAN is a protein that has been identified as a potential drug target and biomarker for various diseases. Despite its complex structure and the difficulty of studying its function, ZAN is an attractive target for small molecules and other therapeutic agents. Further research is needed to understand its specific functions and the precise mechanism of action of its inhibitors.

Protein Name: Zonadhesin

Functions: Binds in a species-specific manner to the zona pellucida of the egg. May be involved in gamete recognition and/or signaling

More Common Targets